{
    "meta": {
        "portal_name": "medicinal-chemistry",
        "language": "en",
        "updated": "20150502"
    },
    "schema": {
        "html:portal": "http://en.recuweb.com/medicinal-chemistry/",
        "graph:videos": "http://en.recuweb.com/graph/v1.0/medicinal-chemistry/medicinal-chemistry/videos.json",
        "graph:news": "http://en.recuweb.com/graph/v1.0/medicinal-chemistry/medicinal-chemistry/news.json",
        "graph:blogs": "http://en.recuweb.com/graph/v1.0/medicinal-chemistry/medicinal-chemistry/blogs.json"
    },
    "items": {
        "4-traders.com/2015/04/futura-medical-future-science-group-launches-medchemnet-first-interactive-community": {
            "title": "Futura Medical: Future Science Group Launches MedChemNet; First Interactive Community for Medicinal...",
            "snippet": "Future Science Group (FSG) has launched MedChemNet, the first online community for those working in the field of medicinal chemistry. The new interactive portal is free to join and offers exclusive content from FSG's leading peer-reviewed journal,...",
            "date": "2015-04-27",
            "categories": "science,chemistry",
            "tags": "journal,leading,leading-peer,peer,interactive,interactive-portal,portal,portal-is-free,free,free-to-join,offers,offers-exclusive,offers-exclusive-content,exclusive,exclusive-content,content,community,future,future_science,future_science_group,science,science_group,group,interactive_community,science_group_launches,group_launches,group_launches_medchemnet,launches,launches_medchemnet,medchemnet,medical,medicinal,fsg,chemistry",
            "recuweb_url": "http://en.recuweb.com/chemistry/4-traders.com/2015/04/futura-medical-future-science-group-launches-medchemnet-first-interactive-community",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://4-traders.com/FUTURA-MEDICAL-PLC-4004178/news/Futura-Medical--Future-Science-Group-Launches-MedChemNet-First-Interactive-Community-for-Medicinal-20262689/"
        },
        "prweb.com/2015/04/future-science-group-launches-medchemnet-first-interactive-community-for-pr-web": {
            "title": "Future Science Group Launches MedChemNet; First Interactive Community for... - PR Web (press...",
            "snippet": "Future Science Group Launches MedChemNet; First Interactive Community for...PR Web (press release)Because medicinal chemistry has become highly interdisciplinary, with exciting breakthroughs coming from collaborative efforts between specialists, we...",
            "date": "2015-04-27",
            "categories": "science,chemistry",
            "tags": "interactive,interactive_community,community,future,future_science,future_science_group,science,science_group,science_group_launches,group,group_launches,group_launches_medchemnet,launches,launches_medchemnet,medchemnet,medicinal,chemistry",
            "recuweb_url": "http://en.recuweb.com/chemistry/prweb.com/2015/04/future-science-group-launches-medchemnet-first-interactive-community-for-pr-web",
            "resource_url": "http://news.google.com/?hl=en&q=medicinal%2Bchemistry&output=atom&nord=1",
            "source_url": "http://prweb.com/releases/2015/04/prweb12678586.htm"
        },
        "dddmag.com/2015/04/taxis-clinical-potential-in-combating-antibiotic-resistance": {
            "title": "TAXIS: Clinical Potential in Combating Antibiotic Resistance...",
            "snippet": "LaVoie, Ph.D., lead author of the poster, professor and chair, Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, and a co-founder of TAXIS Pharmaceuticals. Its unique inhibition of the...",
            "date": "2015-04-27",
            "categories": "university,school,medicinal-chemistry,chemistry",
            "tags": "university,medicinal,medicinal_chemistry,chemistry,professor,department,pharmacy",
            "recuweb_url": "http://en.recuweb.com/chemistry/dddmag.com/2015/04/taxis-clinical-potential-in-combating-antibiotic-resistance",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://dddmag.com/news/2015/04/taxis-clinical-potential-combating-antibiotic-resistance"
        },
        "purdueexponent.org/2015/04/valerie-parker-grand-prix-princess-purdue-exponent": {
            "title": "Valerie Parker Grand Prix Princess - Purdue Exponent...",
            "snippet": "Valerie Parker Grand Prix PrincessPurdue Exponent\"I'm involved in Medicinal Chemistry and Molecular Pharmacology research, Global Partners for the College of Science, Pre-Dental Club, Order of Omega and I'm an anatomy and physiology teaching...",
            "date": "2015-04-27",
            "categories": "anatomy,physiology,teaching,pharmacology,medicinal-chemistry,chemistry,college,science",
            "tags": "pharmacology,medicinal,medicinal_chemistry,chemistry,research,science",
            "recuweb_url": "http://en.recuweb.com/science/purdueexponent.org/2015/04/valerie-parker-grand-prix-princess-purdue-exponent",
            "resource_url": "http://news.google.com/?hl=en&q=medicinal%2Bchemistry&output=atom&nord=1",
            "source_url": "http://purdueexponent.org/features/article_775ffc59-672a-5951-adc3-b464301354a9.html"
        },
        "knowledgespeak.com/2015/04/news-in-detail-knowledgespeak": {
            "title": "news In detail - Knowledgespeak...",
            "snippet": "news In detailKnowledgespeakThe new interactive portal is free to join and offers exclusive content from FSG's leading peer-reviewed journal, Future Medicinal Chemistry, along with industry news, and a platform for members to share insights and...",
            "date": "2015-04-27",
            "categories": "medicinal-chemistry,chemistry",
            "tags": "industry,future,medicinal,medicinal_chemistry,chemistry,journal,leading,leading-peer,peer,interactive,interactive-portal,portal,portal-is-free,free,free-to-join,offers,offers-exclusive,offers-exclusive-content,exclusive,exclusive-content,content,detail,fsg",
            "recuweb_url": "http://en.recuweb.com/chemistry/knowledgespeak.com/2015/04/news-in-detail-knowledgespeak",
            "resource_url": "http://news.google.com/?hl=en&q=medicinal%2Bchemistry&output=atom&nord=1",
            "source_url": "http://knowledgespeak.com/newsArchieveviewdtl.asp?pickUpBatch=2683"
        },
        "bloomberg.com/2015/04/lester-mitscher-ph-d": {
            "title": "Lester Mitscher Ph.D.",
            "snippet": "Prof. Lester A. Mitscher, Ph.D serves as Distinguished Professor of Department of Medicinal Chemistry of University of Kansas. Prof. Mitscher served as a Scientific Advisor of Zalicus Inc. (formerly CombinatoRx, Incorporated). He served as Chairman...",
            "date": "2015-04-25",
            "categories": "medicinal-chemistry,chemistry,university",
            "tags": "medicinal,medicinal_chemistry,chemistry,professor,department,university",
            "recuweb_url": "http://en.recuweb.com/university/bloomberg.com/2015/04/lester-mitscher-ph-d",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry%2Bmedicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://bloomberg.com/research/stocks/private/person.asp?personId=9805576&privcapId=373663"
        },
        "economictimes.indiatimes.com/2015/04/biocon-surges-as-company-files-prospectus-for-syngene-ipo-to-raise": {
            "title": "Biocon surges as company files prospectus for Syngene IPO to raise Rs 600 crore...",
            "snippet": "The public listing of Syngene, which offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology, has been much-delayed. The plan has remained unexecuted since 2012...",
            "date": "2015-04-23",
            "categories": "pharmacology,toxicology,drug-discovery,chemistry,biology",
            "tags": "plan,plan-has-remained,remained,remained-unexecuted,unexecuted,vivo,vivo-pharmacology,pharmacology,pharmacology-and-toxicology,toxicology,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,ing,raise,syngene,syngene_ipo,ipo,files,files-prospectus,prospectus,biocon,crore,public,medicinal,chemistry,biology,delayed",
            "recuweb_url": "http://en.recuweb.com/biology/economictimes.indiatimes.com/2015/04/biocon-surges-as-company-files-prospectus-for-syngene-ipo-to-raise",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://economictimes.indiatimes.com/markets/ipos/fpos/biocon-surges-as-company-files-prospectus-for-syngene-ipo-to-raise-rs-600-crore/articleshow/47016602.cms"
        },
        "enewspf.com/2015/04/students-from-roosevelt-universitys-class-of-2016-present-pharmacy-research-posters": {
            "title": "Students From Roosevelt Universitys Class of 2016 Present Pharmacy Research Posters...",
            "snippet": "Under the direction of Roosevelt Assistant Professor of Medicinal Chemistry Sonali Kurup, the students identified the 4-anilinosubstitutedpyrrolo2,3-dpyrimidine scaffold as a dual inhibitor of EGFR and AURKA. Compound 1,...",
            "date": "2015-04-23",
            "categories": "students,medicinal-chemistry,chemistry,university",
            "tags": "medicinal,medicinal_chemistry,chemistry,professor,pharmacy,research",
            "recuweb_url": "http://en.recuweb.com/university/enewspf.com/2015/04/students-from-roosevelt-universitys-class-of-2016-present-pharmacy-research-posters",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://enewspf.com/latest-news/school-news/60704-students-from-roosevelt-university-s-class-of-2016-present-pharmacy-research-posters.html"
        },
        "dnaindia.com/2015/04/bio-tech-major-biocon-files-prospectus-for-syngene-ipo-to-raise": {
            "title": "Bio-tech major Biocon files prospectus for Syngene IPO to raise Rs 600 crore...",
            "snippet": "The public listing of Syngene, which offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology, has been much-delayed. The plan has remained unexecuted since 2012...",
            "date": "2015-04-22",
            "categories": "pharmacology,toxicology,drug-discovery,chemistry,biology",
            "tags": "plan,plan-has-remained,remained,remained-unexecuted,unexecuted,vivo,vivo-pharmacology,pharmacology,pharmacology-and-toxicology,toxicology,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,ing,raise,syngene,syngene_ipo,ipo,files,files-prospectus,prospectus,biocon,crore,public,medicinal,chemistry,biology,delayed",
            "recuweb_url": "http://en.recuweb.com/biology/dnaindia.com/2015/04/bio-tech-major-biocon-files-prospectus-for-syngene-ipo-to-raise",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://dnaindia.com/money/report-bio-tech-major-biocon-files-prospectus-for-syngene-ipo-to-raise-rs-600-crore-2079786"
        },
        "profit.ndtv.com/2015/04/biocon-to-go-ahead-with-syngene-ipo-listing-likely-in-july": {
            "title": "Biocon to Go Ahead With Syngene IPO, Listing Likely In July...",
            "snippet": "Syngene offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology. Syngene has a research team of over 2,300 scientists.",
            "date": "2015-04-22",
            "categories": "pharmacology,toxicology,drug-discovery,chemistry,biology",
            "tags": "research,vivo,vivo-pharmacology,pharmacology,pharmacology-and-toxicology,toxicology,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,syngene,syngene_ipo,ipo,biocon,ing,medicinal,chemistry,biology",
            "recuweb_url": "http://en.recuweb.com/biology/profit.ndtv.com/2015/04/biocon-to-go-ahead-with-syngene-ipo-listing-likely-in-july",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://profit.ndtv.com/news/corporates/article-biocon-to-go-ahead-with-syngene-ipo-listing-likely-in-july-757311"
        }
    }
}